• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Holy Name to Offer Needle-Free Blood Draws for Inpatients, First Hospital in NJ

Share:

February 17, 2021

What You Should Know:

– Holy Name Medical Center announced that it is the first hospital in New Jersey among a growing number of health systems nationwide to offer needle-free blood draws for inpatients using the PIVO™ device from Velano Vascular.

– As part of this effort, Holy Name is deploying a new telepresence technology, also provided by Velano, to train staff virtually on the PIVO procedure in accordance with COVID-19 safety protocols.

– By adopting this new standard of care known as One-Stick Hospitalization, Holy Name is again leading the charge for better medicine and building on a number of other recent landmark achievements.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

– With this procedure, Holy Name staff can extract high quality blood draws easily and humanely from patients’ indwelling IV lines without requiring additional needle sticks, resulting in a safer, better experience.

– To train staff on proper use of Velano’s technology, Holy Name has deployed Velano Vascular’s virtual training platform. The company’s remotely piloted trainers enable Holy Name staff to receive real-time, bedside training from Velano nurse educators while limiting in-person interaction and exposure during the pandemic.

PIVO: Needle-Free Blood Draw Device

PIVO is a needle-free, single-use, sterile device that temporarily attaches to a peripheral IV catheter to collect a fresh venous sample. Using the existing PIV line as a conduit to the vein, a flexible, internal flow tube is advanced through the PIV, beyond the catheter tip, and into the vessel to collect a blood sample. This flow tube is designed to extend beyond the suboptimal draw conditions around the IV to reach vessel locations where blood flow is optimal for aspiration. Once blood collection is complete, the device is retracted, removed from the PIV, and discarded.

PIVO Benefits for Hospitals & Patients

For hospitals that want to reduce painful blood collection ‘sticks’, preserve patient’s veins, and minimize reliance on central lines for blood draws, PIVO is a revolutionary vascular access device that expands the use of peripheral lines for high-quality blood draws. PIVO provides significant, measurable value in patient experience, organizational risk, operating efficiencies, and overall quality of care.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • RemeGen Completes USD $100 Million Plus in FundingRemeGen Completes USD $100 Million Plus in Funding
  • Maven Clinic, Amazon partner to offer women’s healthcare to Amazon employeesMaven Clinic, Amazon partner to offer women’s healthcare to Amazon employees
  • Avel eCare Acquires Virtual Hospitalist Provider Fident HealthAvel eCare Acquires Virtual Hospitalist Provider Fident Health
  • Meridian Bioscience Signs Definitive Agreement to Acquire Exalenz Bioscience; Adds State-Of-The-Art Urea Breath Test Diagnostics PlatformMeridian Bioscience Signs Definitive Agreement to Acquire Exalenz Bioscience; Adds State-Of-The-Art Urea Breath Test Diagnostics Platform
  • Biotech PTC to acquire Lynnfield’s Agilis in $200M dealBiotech PTC to acquire Lynnfield’s Agilis in $200M deal
  • Transcat, Inc. Accelerates Operational Excellence Initiatives with Acquisition of Calibration Software CompanyTranscat, Inc. Accelerates Operational Excellence Initiatives with Acquisition of Calibration Software Company
  • Global M&A Activity is Predicted to Increase in Second Half of 2021Global M&A Activity is Predicted to Increase in Second Half of 2021
  • EOM Pharmaceuticals, Inc. and Immunocellular Therapeutics, Ltd. Announce Entry Into and Close of Definitive Merger AgreementEOM Pharmaceuticals, Inc. and Immunocellular Therapeutics, Ltd. Announce Entry Into and Close of Definitive Merger Agreement

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications